575 Pill - blue & white oval, 24mm
Generic Name: levetiracetam
Pill with imprint 575 is Blue & White, Oval and has been identified as Elepsia XR 1500 mg. It is supplied by Sun Pharmaceutical Industries Limited.
Elepsia XR is used in the treatment of Seizures; Epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Elepsia XR 1500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 575
Elepsia XR
- Generic Name
- levetiracetam
- Imprint
- 575
- Strength
- 1500 mg
- Color
- Blue & White
- Size
- 24.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Limited
- National Drug Code (NDC)
- 47133-0575
- Inactive Ingredients
-
povidone,
hypromelloses,
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer,
silicon dioxide,
magnesium stearate,
magnesium silicate,
microcrystalline cellulose,
crospovidone,
sodium lauryl sulfate,
FD&C Blue No. 1,
ethylcellulose,
dibutyl sebacate,
triethyl citrate,
polysorbate 20,
polyvinyl alcohol,
polyethylene glycol,
polysorbate 80,
shellac,
ferrosoferric oxide,
butyl alcohol,
propylene glycol,
ammonia
Note: Inactive ingredients may vary.
Related images for "575"
Topiramate
Learn about topiramate, an anticonvulsant used for seizures, migraine prevention, and weight loss ...
More about Elepsia XR (levetiracetam)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Keppra, Keppra XR, Spritam, Roweepra, Roweepra XR
Professional resources
Other brands
Keppra, Keppra XR, Spritam, Roweepra, Roweepra XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.